Loading patent…
AssigneeJapan Tobacco Inc.
InventorsIkuo Mitani, Yosuke Ogoshi, Takuya Matsui, Masahiro Yokota, Masakazu Terashita, Dai Motoda, Kazuhito Ueyama, Hiroyuki Abe, Takahiro Hotta, Takashi Ito
Estimating the term…
The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.
A compound represented by the following formula [I], or a pharmaceutically acceptable salt thereof, or a solvate thereof:
A compound represented by the following formula [I-1] or a pharmaceutically acceptable salt thereof, or a solvate thereof:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
A compound represented by the following formula:
Dependencies are inferred from the claim text.